XWELL Inc

XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Treat, and Corporate and Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment consists of access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

XWELL Inc reports revenue growth and cost efficiency in Q3

XWELL Inc delivered a solid performance in Q3 2024, marked by revenue growth, cost reduction, and strong liquidity, positioning the company for future growth.
While facing challenges such as operating losses and execution risks, XWELL's strategic initiatives and financial stability provide a foundation for overcoming obstacles.
By leveraging opportunities in brand expansion, new locations, and customer experience enhancement, XWELL can drive sustainable growth and competitive advantage in the market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Naples Wax Center, Treat, and Corporate & Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Naples Wax Center segment is focused on the products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.

Ginkgo Bioworks Holdings

The program can be an effective early warning system for public health and national security officials, leveraging voluntary nasal and wastewater sampling from international travelers at major U.S. airports BOSTON , Nov. 6, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and XWELL, Inc. (Nasdaq: XWEL) today announced they are expanding their work with the U.S. Centers for Disease Control and Prevention's (CDC's) Traveler-based Genomic Surveillance program (TGS) to test for more than 30 additional priority pathogens, in addition to SARS-CoV-2. TGS is a flexible, multimodal platform that consists of three complementary approaches of sample collection from arriving international travelers at U.S. airports, including voluntary nasal swabbing, aircraft wastewater, and airport wastewater sampling to enhance early detection of new SARS-CoV-2 variants and other pathogens, and fills gaps in global surveillance.

Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens

Highlights the Recent Acquisition of Naples Wax Center as Launch Pad for XWELL's Out of Airport Strategy Highlights the Recent Acquisition of Naples Wax Center as Launch Pad for XWELL's Out of Airport Strategy

XWELL's CEO Scott Milford Discusses Strategic Growth Plans During Recent Investor Fireside Chat

Proceeds from select XpresSpa nail care services to be donated to Susan G. Komen Proceeds from select XpresSpa nail care services to be donated to Susan G. Komen

XWELL Celebrates Breast Cancer Awareness Month with Philanthropic Nail Care Program

Scott Milford to Present at Water Tower Research Fireside Chat Series on Wednesday, October 4, 2023, at 2:30 p.m. E.T. Scott Milford to Present at Water Tower Research Fireside Chat Series on Wednesday, October 4, 2023, at 2:30 p.m. E.T.

XWELL's CEO Scheduled to Present at Upcoming Investor Fireside Chat on October 4, 2023

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), announced today that it will effect a 1-for-20 reverse stock split of its common stock effective at 5:00 pm Eastern Time on Wednesday, September 27, 2023. Shares of XWELL's common stock are expected to begin trading on a split-adjusted basis when markets open on Thursday, September 28, 2023.

XWELL, Inc. Announces 1-for-20 Reverse Stock Split

NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, continues to evolve its service offerings with the introduction of a proprietary stretching service for XpresSpa locations nationally.

XWELL Introduces New Stretch Service at XpresSpa

Transaction represents the first step in building XWELL's retail portfolio outside the airport and positions the Company for revenue growth and profitability Transaction represents the first step in building XWELL's retail portfolio outside the airport and positions the Company for revenue growth and profitability

XWELL Grows Footprint Outside the Airport with Acquisition of Naples Wax Center

XWELL, Inc. (NASDAQ:XWEL ) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Suzanne Scrabis - CFO Scott Milford - CEO Operator Greetings. Welcome to XWELL's Second Quarter 2023 Earnings Conference Call.

XWELL, Inc. (XWEL) Q2 2023 Earnings Call Transcript

Since August 2021, the program has served as a critical monitoring system for biological threats, leveraging voluntary sampling from international travelers at major U.S. airports Since August 2021, the program has served as a critical monitoring system for biological threats, leveraging voluntary sampling from international travelers at major U.S. airports

XWELL Extends Collaboration with Centers for Disease Control and Prevention's Traveler-Based Genomic Surveillance Program

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) --  XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today reported results for the second quarter ended June 30, 2023.

XWELL, Inc. Reports Second Quarter 2023 Results

NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release second quarter 2023 financial results on Monday, August 14, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.

XWELL, Inc. to Announce Second Quarter 2023 Financial Results on Monday, August 14

NEW YORK, July 20, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, in partnership with Clockwork, the pioneer in robotics for the beauty industry, today launched the use of Clockwork's next generation, fully autonomous, AI-powered express manicure in the XpresSpa® location at Miami International Airport (MIA) in Miami, Florida. MIA's North Terminal, Concourse D is the second airport location in the world to feature robot manicures following the debut at John F.

XpresSpa Debuts Clockwork Robotic Manicures at Miami International Airport

Refreshed program furthers XWELL's transformation to meet the needs of today's travelers Refreshed program furthers XWELL's transformation to meet the needs of today's travelers

XWELL Unveils “XWELL Rewards” Loyalty Program

NEW YORK, July 13, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), an authority in health and wellness solutions for people on the go, today announced the appointment of Suzanne A. Scrabis as Chief Financial Officer of the Company, effective July 10, 2023. Suzanne brings to the Company more than 25 years of deep financial and operating experience across all stages of growth.

XWELL, Inc. Appoints Suzanne Scrabis as Chief Financial Officer

NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in health and wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2023.

XWELL, Inc. Reports First Quarter 2023 Results

NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release first quarter 2023 financial results on Monday, May 15, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.

XWELL, Inc. to Announce First Quarter 2023 Financial Results on Monday, May 15

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), an authority in health and wellness solutions for people on the go, today announced that Valerie Lightfoot has been named Chief Financial Officer, effective June 12, 2023. Ms. Lightfoot joins XWELL with over 25 years of financial leadership experience. During her career, she has helped companies successfully execute organic growth initiatives, integrate acquisitions as well as implement process improvements and achieve improving cashflow.

XWELL, Inc. Names Valerie Lightfoot Chief Financial Officer

Fully autonomous and customizable massage therapy services through WellnessSpace Brands and Human Touch® now available at seven spas Fully autonomous and customizable massage therapy services through WellnessSpace Brands and Human Touch® now available at seven spas

XWELL Unveils Automated Massage Chairs at XpresSpa Locations Across the U.S.

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), an authority in health and wellness solutions for people on the go, today announced that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has been granted an additional 180-days to regain compliance with Nasdaq's minimum Bid Price Requirement. The Notice has no immediate effect on the listing or trading of the Company's common stock, which continues to trade on the Nasdaq Capital Market under the symbol “XWEL”.

XWELL, Inc. Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule

XWELL, Inc. (XWEL) Q4 2022 Earnings Call Transcript.

XWELL, Inc. (XWEL) Q4 2022 Earnings Call Transcript

NEW YORK, April 17, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), an authority in health and wellness solutions for people on the go, today reported results for the year ended December 31, 2022.

XWELL, Inc. Reports Fiscal Year 2022 Results

NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release fiscal year 2022 financial results on Monday, April 17, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.

XWELL, Inc. to Announce 2022 Financial Results on Monday April 17

NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in health and wellness solutions for people on the go, today announced plans to file a Form 12b-25 with the U.S. Securities and Exchange Commission regarding its Annual Report on Form 10-K for the year ended December 31, 2022. The Company requires additional time to complete a review in accordance with generally accepted accounting principles to assess the amount of a non-cash impairment charge required for the fourth quarter of 2022. The Form 12b-25 provides the Company with an additional 15 calendar days to complete its assessment and allows its independent registered public accounting firm extra time to complete its audit of the Company's financial statements before filing its Form 10-K.

XWELL Announces Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K And Provides Preliminary FY2022 Operating Update

XWELL debuts first-of-its-kind beauty experience at airports with Clockwork's manicure robots XWELL debuts first-of-its-kind beauty experience at airports with Clockwork's manicure robots

First Robot Manicure Unveiled at XpresSpa at John F. Kennedy International Airport

The program is an effective early warning system for viral variants, leveraging voluntary sampling from international travelers at major U.S. airports BOSTON and NEW YORK , Jan. 17, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) and XWELL, Inc. (Nasdaq: XWEL) today announced that they have expanded their support for the Centers for Disease Control and Prevention's (CDC's) Traveler-based Genomic Surveillance program to include a pilot study monitoring influenza viruses in addition to SARS-CoV-2. The partners continue to grow the program's capabilities to provide an additional source of viral surveillance to inform the selection of influenza vaccine viruses for the forthcoming 2023-2024 flu season.

News for XWELL Inc Stock (XWEL)